Cite

HARVARD Citation

    Zhang, P. et al. (2018). Impact of heavy smoking on the benefits from first-line EGFR-TKI therapy in patients with advanced lung adenocarcinoma. Medicine. 97 (9), p. . [Online]. 
  
Back to record